These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21875018)

  • 1. Capillaroscopy as a prognostic tool for the development of connective tissue disease in patients with Raynaud's phenomenon.
    Damjanov N; Pavlov-Dolijanović S; Zlatanović M
    Reumatizam; 2010; 57(2):119-20. PubMed ID: 21875018
    [No Abstract]   [Full Text] [Related]  

  • 2. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nailfold capillaroscopy in the evaluation of Raynaud's phenomenon and undifferentiated connective tissue disease].
    Cortes S; Clemente-Coelho P
    Acta Reumatol Port; 2008; 33(2):203-9. PubMed ID: 18604184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nailfold capillaroscopy in children and adolescents with rheumatic diseases].
    Petry DG; Terreri MT; Len CA; Hilário MO
    Acta Reumatol Port; 2008; 33(4):395-400. PubMed ID: 19107084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermoscopy findings of nail fold capillaries in connective tissue diseases.
    Hasegawa M
    J Dermatol; 2011 Jan; 38(1):66-70. PubMed ID: 21175758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology?
    Cutolo M; Smith V
    Rheumatology (Oxford); 2013 Nov; 52(11):1933-40. PubMed ID: 23620555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Raynaud's phenomenon and connective tissue diseases].
    Guilmot JL; Diot E; Lasfargues G; Boissier C
    Rev Prat; 1998 Oct; 48(15):1647-52. PubMed ID: 9814065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications for nailbed capillaroscopy in Raynaud's phenomenon].
    Chamot AM; Monti M
    Schweiz Med Wochenschr; 1985 Dec; 115(51):1852-7. PubMed ID: 4089584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raynaud's phenomenon: factors of prognostic significance for the development of connective tissue disease. Relevance of vascular and immunological tests.
    Kallenberg CG; The TH; Wouda AA
    Neth J Med; 1986; 29(11):386-92. PubMed ID: 3808141
    [No Abstract]   [Full Text] [Related]  

  • 11. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM; Voskuyl AE; Serné EH; Smulders YM
    Ned Tijdschr Geneeskd; 2009; 153():B216. PubMed ID: 19785782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphologic study of the microcirculation in connective tissue diseases].
    Cantatore FP; Corrado A; Covelli M; Lapadula G
    Ann Ital Med Int; 2000; 15(4):273-81. PubMed ID: 11202629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Periungueal capillaroscopy: an easy and reliable method to evaluate all microcirculation diseases].
    Jammal M; Kettaneh A; Cabane J; Tiev K; Toledano C
    Rev Med Interne; 2015 Sep; 36(9):603-12. PubMed ID: 25890839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Causes of Raynaud's phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease.
    Yin H; Lu L
    Rheumatology (Oxford); 2022 Jul; 61(7):e188-e189. PubMed ID: 34864903
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: Causes of Raynaud's phenomenon and the predictive laboratory and capillaroscopy features for the evolution to a definite connective tissue disease: reply.
    Shenavandeh S; Ajri M; Hamidi S
    Rheumatology (Oxford); 2022 Jul; 61(7):e190-e191. PubMed ID: 34864926
    [No Abstract]   [Full Text] [Related]  

  • 17. Capillaroscopy.
    Cutolo M; Pizzorni C; Sulli A
    Best Pract Res Clin Rheumatol; 2005 Jun; 19(3):437-52. PubMed ID: 15939368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CysLT1 receptor inhibition in patients with Raynaud's phenomenon: capillaroscopic evidence of the role of leukotriene.
    Azevedo MN; Bernardini EM; Salles EF; Heinzmann F; Marconde F; Mello T; Gomes BE
    Rev Bras Reumatol; 2012; 52(1):30-2. PubMed ID: 22286643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanic hands: clinical and capillaroscopy manifestations of patients with connective tissue diseases presented with and without mechanic hands.
    Shenavandeh S; Habibi S; Habibi Y; Nazarinia M
    Clin Rheumatol; 2019 Sep; 38(9):2309-2318. PubMed ID: 30635856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.